CLINICAL TRIALS PROFILE FOR NEMBUTAL
✉ Email this page to a colleague
All Clinical Trials for NEMBUTAL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00878345 ↗ | Dexmedetomidine Versus Pentobarbital for Pediatric Procedural Sedation | Withdrawn | Washington University School of Medicine | N/A | 2009-11-01 | The investigators believe dexmedetomidine will provide superior sedation with reduced side effects and reduced time to discharge compared with pentobarbital. The investigators have developed sedation protocols with pentobarbital and dexmedetomidine in our ambulatory procedure center. These protocols are both routinely used for sedation in our unit. The investigators propose to study these two protocols in children ages 6 months to 6 years presenting to the ambulatory procedure center for non-painful procedural sedation. The investigators will compare failure of sedation, side effect profile, recovery and discharge times between the two pharmacologic protocols. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NEMBUTAL
Condition Name
Clinical Trial Locations for NEMBUTAL
Trials by Country
Clinical Trial Progress for NEMBUTAL
Clinical Trial Phase
Clinical Trial Sponsors for NEMBUTAL
Sponsor Name